Welcome to LookChem.com Sign In|Join Free
  • or
1-Hydroxymethyl-cyclopropanecarboxylic acid ethyl ester is a chemical compound with the molecular formula C7H12O3. It is an ester derivative of 1-hydroxymethyl-cyclopropanecarboxylic acid, where the hydroxyl group is replaced by an ethoxy group. This organic compound is characterized by a cyclopropane ring, which is a three-membered carbon ring, and a hydroxymethyl group attached to it. The ethyl ester group further modifies the molecule, making it a versatile building block in organic synthesis. It is used in the synthesis of various pharmaceuticals and agrochemicals due to its unique structural features. The compound is known for its potential applications in the development of new drugs and chemical intermediates, particularly those that can exploit the strained ring system of cyclopropane for biological activity.

3697-68-5

Post Buying Request

3697-68-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3697-68-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 3697-68-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,6,9 and 7 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 3697-68:
(6*3)+(5*6)+(4*9)+(3*7)+(2*6)+(1*8)=125
125 % 10 = 5
So 3697-68-5 is a valid CAS Registry Number.

3697-68-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H62277)  Ethyl 1-(hydroxymethyl)cyclopropanecarboxylate, 97%   

  • 3697-68-5

  • 250mg

  • 491.0CNY

  • Detail
  • Alfa Aesar

  • (H62277)  Ethyl 1-(hydroxymethyl)cyclopropanecarboxylate, 97%   

  • 3697-68-5

  • 1g

  • 1571.0CNY

  • Detail
  • Alfa Aesar

  • (H62277)  Ethyl 1-(hydroxymethyl)cyclopropanecarboxylate, 97%   

  • 3697-68-5

  • 5g

  • 6552.0CNY

  • Detail

3697-68-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 1-hydroxymethyl-cyclopropanecarboxylate

1.2 Other means of identification

Product number -
Other names ethyl 1-(hydroxymethyl)cyclopropane-1-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3697-68-5 SDS

3697-68-5Relevant academic research and scientific papers

ANTIVIRAL PYRIDOPYRAZINEDIONE COMPOUNDS

-

Paragraph 0736-0737, (2020/04/09)

The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.

BICYCLIC KETONE COMPOUNDS AND METHODS OF USE THEREOF

-

Page/Page column 124; 125, (2019/02/02)

The invention provides novel compounds having the general formula (I): (I) wherein R1, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

-

Paragraph 0451; 0452, (2016/05/02)

This document discloses molecules having the following formula (“Formula One”): and processes related thereto.

TRI-HETEROCYCLIC DERIVATIVES, PREPARATION PROCESS AND USES THEREOF

-

Paragraph 0124; 0371 0372, (2014/11/13)

The present invention relates to a tri-heterocyclic derivatives, preparation process and uses thereof, specifically relates to a tri-heterocyclic derivatives of the formula (I) or a pharmaceutically acceptable salt thereof, preparation process, and further relates to a pharmaceutically acceptable composition comprising compounds of formula (I), or a pharmaceutically acceptable salt thereof, and their pharmaceutical use as inhibitors of kinase.

TRI-HETEROCYCLIC DERIVATIVES, PREPARATION PROCESS AND USES THEREOF

-

Page/Page column 43, (2013/07/05)

The present invention relates to a tri-heterocyclic derivatives, preparation process and uses thereof, specifically relates to a tri-heterocyclic derivatives of the formula (I) or a pharmaceutically acceptable salt thereof, preparation process, and further relates to a pharmaceutically acceptable composition comprising compounds of formula (I), or a pharmaceutically acceptable salt thereof, and their pharmaceutical use as inhibitors of kinase

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

-

Paragraph 0400; 0401, (2013/05/09)

This document discloses molecules having the following formula (“Formula One”): and processes related thereto.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

-

Paragraph 0450-0451, (2013/11/06)

This document discloses molecules having the following formula (“Formula One”): and processes related thereto.

[1,2,4]TRIAZOLOPYRIDINES AND THEIR USE AS PHOSPODIESTERASE INHIBITORS

-

Page/Page column 15, (2013/07/05)

The present invention relates to novel [1,2,4]triazolopyridine compounds with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.

NOVEL HETEROARYL-AMINO DERIVATIVES

-

Page/Page column 39, (2013/05/09)

Disclosed is a compound of formula (I), wherein R1, R2, L, Rm and Rn are as defined herein. The compound of formula (I) may be used in preventing and/or treating acyl CoA-diacylglycerol acyltransferase 1(DGAT-1) related diseases, such as obesity, coronary disease, hypertension, hyperlipidemia, arteriosclerosis, type II diabetes, stroke, hepatitis C, and the like.

Pesticidal Compositions and Processes Related Thereto

-

Page/Page column 38, (2012/05/07)

This document discloses molecules having the following formula (“Formula One”): and processes related thereto.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3697-68-5